drugset / Trial / NCT03426605
A Study of LAM-003 in Patients With Acute Myeloid Leukemia
NaSequentialOpen-labelTreatment
Summary
A Phase 1 Dose-Escalation Study of LAM-003 in Patients with Acute Myeloid Leukemia
Timeline
- Start
- 2018-01-16
- Primary completion
- 2020-02-20
- Completion
- 2020-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAM-003 | Unknown | 200 mg | Oral |
| Subject | LAM-003 | Unknown | 300 mg | Oral |
| Subject | LAM-003 | Unknown | 450 mg | Oral |